Kyverna Therapeutics, Inc. ( (KYTX)) has provided an update. On December 15, 2025, Kyverna Therapeutics announced positive topline data from its Phase 2 trial of mivocabtagene autoleucel (miv-cel) for ...

At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA) vaccine designed to help prevent triple-negative breast cancer (TNBC), ...

Fulcrum Therapeutics (FULC) on Saturday reported positive initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease. “We are highly ...

New research offers clearer insight into how phase transitions unfold at the atomic scale in real materials. When ice turns into water, the change happens almost instantly. Once the melting ...

Collagen is the most abundant protein in the human body and has an important role in healthy tissue as well as in a range of prevalent diseases. Medical research and diagnostics hence call for means ...

Editor’s note: This story has been corrected to accurately reflect findings from a Public Religion Research Institute survey. The Department of Homeland Security (DHS) is planning to change its ...

MAINZ, Germany, and PRINCETON, USA, December 9, 2025 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Bristol Myers Squibb Company (NYSE: BMY, “BMS”) today announced the first interim data from a global ...

BriaCell (BCTX) Therapeutics presents positive Phase 2 survival, and Phase 3 biomarker data across three clinical posters at the 2025 San Antonio Breast Cancer Symposium, SABCS, taking place December ...

Barreling toward the end of its cash runway, GRI Bio has shared phase 2a data in idiopathic pulmonary fibrosis (IPF) and made the case for further development of its potentially disease-modifying ...

Seoul's Kospi is on track to close the year with a 72% gain. Other Asian stock markets are positive, and in the US, the Nasdaq is soaring despite bubble fears. Milan, up 30% since the beginning of the ...